title: Acknowledging the relevance of cognitive changes in cancer patients: perspectives of oncology practitioners in Asia.
abstract: OBJECTIVE
  Previous studies have suggested that cognitive impairment can affect cancer patients' health-related quality of life (HRQoL) and daily functioning. This study investigated oncology practitioners' perceptions of the relevance, effects, and causes of such cognitive changes in cancer patients, and their awareness of coping strategies.
  
  
  METHODS
  Oncology practitioners completed a self-administered cross-sectional survey. Practitioners were recruited from four major cancer centers in Singapore and Thailand, and through a regional cancer meeting that took place in Singapore in September 2011.
  
  
  RESULTS
  The sample (n = 193) consisted of nurses (51.3 %), oncologists (35.2 %), and pharmacists (13.5 %). Cognitive changes were frequently observed among cancer patients, particularly in the domains of memory (77.1 %) and concentration (74.6 %). The majority (86.5 %) of respondents agreed that cognitive changes adversely effected patients' HRQoL. The majority (65.3 %) of the respondents also recognized the need to implement routine neuropsychological assessments in clinical settings. The following factors were perceived as contributing to cognitive changes: aging (77.6 %), cancer-related fatigue (65.2 %), and anxiety (61.2 %). Compared with other healthcare professionals, oncologists were less likely to agree that chemotherapy was a major contributing factor to cognitive changes (25.0 % vs. 9.8 %, p = 0.038). Psychosocial support and the use of complementary alternative medicines (CAM) were identified as coping strategies for cognitive changes.
  
  
  CONCLUSIONS
  Healthcare professionals do not perceive a uniform set of contributing factors to cognitive impairment among cancer patients, although they all acknowledge that cancer patients' experience of cognitive impairment is a relevant issue.
  
  
  CONCLUSIONS
  It is important to equip clinicians with the knowledge necessary for monitoring and managing the cognitive disturbances and psychological distress experienced by at risk patients in a clinical setting.
authors: Department of Pharmacy, National University of Singapore, 18 Science Drive, Block S4, Singapore, 117543, Singapore.
authors: Yin Ting
authors: YT
authors: Cheung
authors: Maung
authors: M
authors: Shwe
authors: Earl Hsien Jie
authors: EH
authors: Tan
authors: Wai Keung
authors: WK
authors: Chui
authors: Raymond
authors: R
authors: Ng
authors: Alexandre
authors: A
authors: Chan
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D001208:Asia; D003072:Cognition Disorders / Q000139:chemically induced* / Q000517:prevention & control; D003430:Cross-Sectional Studies; D006282:Health Personnel / Q000523:psychology*; D006801:Humans; D008495:Medical Oncology; D009369:Neoplasms / Q000188:drug therapy* / Q000523:psychology*; D011795:Surveys and Questionnaires
chemical_list: D000970:Antineoplastic Agents
references: Cancer. 2011 Jan 1;117(1):190-6
references: 20737560
references: Ann Oncol. 2008 Apr;19(4):623-9
references: 17974553
references: Oncol Nurs Forum. 2005 Nov 03;32(6):1151-63
references: 16270111
references: Nature. 2000 Nov 9;408(6809):248-54
references: 11089982
references: Menopause. 2007 Nov-Dec;14(6):995-8
references: 17898668
references: Lancet Oncol. 2011 Jul;12(7):703-8
references: 21354373
references: Support Care Cancer. 2012 Jan;20(1):149-57
references: 21229270
references: Psychooncology. 2011 Jul;20(7):681-97
references: 20690112
references: Psychooncology. 2010 Nov;19(11):1127-38
references: 20020424
references: Breast Cancer Res Treat. 2012 Jan;131(2):599-606
references: 21901384
references: Nat Rev Cancer. 2007 Mar;7(3):192-201
references: 17318212
references: Cancer Invest. 2007 Sep;25(6):373-7
references: 17882646
references: Curr Oncol. 2011 Oct;18(5):e218-26
references: 21980253
references: J Clin Oncol. 2000 Jul;18(14):2695-701
references: 10894868
references: J Support Oncol. 2007 Nov-Dec;5(10):499-504
references: 18240673
references: Cancer Treat Res. 2009;151:387-419
references: 19593525
references: J Clin Oncol. 2012 Oct 20;30(30):3675-86
references: 23008308
references: Support Care Cancer. 2011 Oct;19(10):1647-56
references: 20820813
references: J Clin Oncol. 2010 Oct 10;28(29):4434-40
references: 20837957
references: Cancer. 2004 Aug 1;101(3):466-75
references: 15274059
references: Psychooncology. 2012 Feb;21(2):176-86
references: 22271538
references: Psychooncology. 2009 Mar;18(3):248-57
references: 18756583
references: Psychooncology. 2006 Oct;15(10):921-30
references: 16477674
references: Cancer. 2004 Jun 1;100(11):2292-9
references: 15160331
references: Breast Cancer Res Treat. 2008 Jul;110(1):143-52
references: 17674194
references: Palliat Support Care. 2007 Sep;5(3):273-80
references: 17969831
references: Psychooncology. 2007 Aug;16(8):772-7
references: 17152119
references: Psychooncology. 2012 Oct;21(10):1132-5
references: 21769988
references: Acta Oncol. 2009;48(1):18-26
references: 19031161
references: Psychooncology. 2011 Dec;20(12):1251-8
references: 21254307
references: Psychooncology. 2012 Apr;21(4):343-50
references: 21882287
references: J Clin Oncol. 1998 Jul;16(7):2522-7
references: 9667273
references: Cancer Nurs. 2011 Sep-Oct;34(5):385-92
references: 21242770
references: Ann Oncol. 2011 Sep;22(9):1939-1947
references: 21289366
references: Cancer. 2007 May 1;109(9):1905-13
references: 17351951
references: Breast Cancer Res Treat. 2011 Feb;126(1):221-6
references: 21046229
references: Support Care Cancer. 2008 Jun;16(6):577-83
references: 17972110
references: J Cancer Surviv. 2009 Dec;3(4):223-32
references: 19760150
references: J Affect Disord. 2012 Feb;136(3):895-901
references: 21975139
references: Crit Rev Oncol Hematol. 2012 Jul;83(1):99-111
references: 22015329
references: Ann Oncol. 2009 Dec;20(12):1929-35
references: 19622510
references: Ann Oncol. 2009 Apr;20(4):752-7
references: 19150956
references: J Neurooncol. 2012 Mar;107(1):165-74
references: 21964738
references: Can Oncol Nurs J. 2008 Fall;18(4):180-92
references: 19580104
references: Br J Cancer. 1996 Nov;74(10):1674-9
references: 8932354
references: Psychooncology. 2012 Jan;21(1):43-53
references: 20967847
references: Support Care Cancer. 2012 Jun;20(6):1235-42
references: 21688163
references: Ann Oncol. 2012 Oct;23(10):2547-2552
references: 22396443
references: Psychooncology. 2009 Jun;18(6):674-8
references: 19021129
references: J Int Neuropsychol Soc. 2003 Nov;9(7):967-82
references: 14738279
references: Clin Pharmacol Ther. 2011 Sep;90(3):366-76
references: 21814191
references: J Psychiatry Neurosci. 2005 Mar;30(2):100-7
references: 15798785
references: Expert Rev Anticancer Ther. 2012 Feb;12(2):255-69
references: 22316373
references: Med J Aust. 2006 Oct 2;185(7):377-9
references: 17014406
references: Cancer Causes Control. 2004 Nov;15(9):903-10
references: 15577292